Drug development for the treatment of onchocerciasis: Population pharmacokinetic and adverse events modeling of emodepside

by Frauke Assmus, Richard M. Hoglund, Frédéric Monnot, Sabine Specht, Ivan Scandale, Joel Tarning
Published 2022

The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern

by Rana Abdelnabi, Caroline S. Foo, Dirk Jochmans, Laura Vangeel, Steven De Jonghe, Patrick Augustijns, Raf Mols, Birgit Weynand, Thanaporn Wattanakul, Richard M. Hoglund, Joel Tarning, Charles E. Mowbray, Peter Sjö, Fanny Escudié, Ivan Scandale, Eric Chatelain, Johan Neyts
Published 2022

Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2

by Jean Sélim Driouich, Maxime Cochin, Franck Touret, Paul Rémi Petit, Magali Gilles, Grégory Moureau, Karine Barthélémy, Caroline Laprie, Thanaporn Wattanakul, Palang Chotsiri, Richard M. Hoglund, Joel Tarning, Laurent Fraisse, Peter Sjö, Charles E. Mowbray, Fanny Escudié, Ivan Scandale, Eric Chatelain, Xavier de Lamballerie, Caroline Solas, Antoine Nougairède
Published 2022